Author
Hiro‐omi Kanayama
Also Known As
H Kanayama, H O Kanayama, H. Kanayama, H.-o. Kanayama, HIRO-OMI KANAYAMA, HIROOMI KANAYAMA, HIRO‐OMI KANAYAMA, Hiro-Omi Kanayama, Hiro-omi KANAYAMA, Hiro-omi Kanayama
332
Publications
6.2K
Citations
43
H-Index
122
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 26 | 43 | 2.8K |
2 | Biochemistry | 5 | 5 | 184 |
3 | Natural Sciences | 4 | 4 | 217 |
4 | Health Sciences | 3 | 3 | 78 |
5 | Public Health | 1 | 1 | 28 |
Hiro‐omi Kanayama
×
113
Publications
5.7K
Citations
43
H-Index
| Year | Citations | |
|---|---|---|
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, First-line TherapyUrologyChemotherapy Versus ChemotherapyGenitourinary CancerMedicine | 2021 | 627 |
2001 | 403 | |
1998 | 190 | |
2003 | 182 | |
2005 | 166 | |
1991 | 165 | |
2021 | 126 | |
2011 | 123 | |
1992 | 122 | |
2003 | 116 |
Page 1
Page 1